EUVIMEDEUVIMED entdecken
Open Access

Ionic Liquid‐Mediated Delivery of Ruxolitinib to Skin Using an Adhesive Topical Hydrogel System

Nicole B Day iD, Christopher R Orear, Alysha N Hunter iD, Matthew M C Kwan iD, Christine M Hamadani iD, Ava d'Auvergne, Junling Guo iD, Eden E L Tanner iD, C Wyatt Shields iD

Advanced Healthcare Materials · 2025-10 · 14 (27)

DOI: 10.1002/adhm.202501838 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 22.07.2025. Verfasst von Nicole B Day und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, CO, 80303, USA. Hauptthemen laut MEDLINE: Hydrogels, Pyrazoles, Ionic Liquids, Skin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health (NIH), NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Delivery of many drug types to the skin is prohibited by the stratum corneum, and drugs that can penetrate the epidermal barrier (e.g., small, nonpolar molecules) often have limited permeation in the dermis. Ionic liquids (ILs) are well‐known penetration enhancers, yet, achieving sustained, controlled drug release from ILs alone remains a significant challenge. Herein, ILs are incorporated into a removable, phenolic‐functionalized tissue‐adhesive hydrogel system for the treatment of atopic dermatitis. The hydrogel, enriched with galloyl groups from plant polyphenols, provides robust skin adhesion, effectively securing IL and ruxolitinib (Janus kinase (JAK) 1/2 inhibitor)‐loaded nanoparticles at the target site and enabling sustained delivery of the IL‐carried ruxolitinib into the dermis. The IL choline trans‐2‐butenoic acid (CA2BE) 1:1 can be embedded within the adhesive hydrogel without compromising its mechanical properties or inflaming macrophages. Importantly, the IL‐mediated transport of drug into the skin causes a significant increase in ruxolitinib accumulation within the dermis, surpassing that of a clinical ointment analog. By combining efficient skin permeation, controlled release, and strong adhesion, this multifunctional platform offers significant potential for topical drug delivery across a range of skin disorders, extending beyond atopic dermatitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsPyrazolesIonic LiquidsSkinDrug Delivery SystemsPyrimidinesAnimalsNitrilesMiceDermatitis, AtopicHumansNanoparticlesAdministration, Cutaneous

Stichwörter der Autor:innen

controlled releasedrug deliveryhydrogelsionic liquidsphenol

Substanzen

ruxolitinibPyrimidinesHydrogelsNitrilesPyrazolesIonic Liquids

Autor:innen und Institutionen

  • Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, CO, 80303, USA.
  • Biomedical Engineering Program, University of Colorado Boulder, Boulder, CO, 80303, USA.
  • Department of Chemistry and Biochemistry, University of Mississippi, Oxford, MS, 38677, USA.
  • Materials Science & Engineering Program, University of Colorado Boulder, Boulder, CO, 80303, USA.
  • BMI Center for Biomass Materials and Nanointerfaces, National Engineering Laboratory for Clean Technology of Leather Manufacture, Ministry of Education (MOE) Key Laboratory of Leather Chemistry and Engineering, and Coll…

ORCID-Profile: Nicole B Day, Alysha N Hunter, Matthew M C Kwan, Christine M Hamadani, Junling Guo, Eden E L Tanner, C Wyatt Shields

Förderung

  • NCI NIH HHS
  • National Institutes of Health (NIH)
  • NIGMS NIH HHS
  • NIH HHS

Zitieren

APA

Day, N. B., Orear, C. R., Hunter, A. N., Kwan, M. M. C., Hamadani, C. M., d'Auvergne, A., Guo, J., Tanner, E. E. L., & Shields, C. W. (2025). Ionic Liquid‐Mediated Delivery of Ruxolitinib to Skin Using an Adhesive Topical Hydrogel System. Advanced Healthcare Materials, 14(27). https://doi.org/10.1002/adhm.202501838

Vancouver

Day NB, Orear CR, Hunter AN, Kwan MMC, Hamadani CM, d'Auvergne A, et al. Ionic Liquid‐Mediated Delivery of Ruxolitinib to Skin Using an Adhesive Topical Hydrogel System. Advanced Healthcare Materials. 2025;14(27). doi:10.1002/adhm.202501838

BibTeX
@article{Day2025,
  author = {Day, Nicole B and Orear, Christopher R and Hunter, Alysha N and Kwan, Matthew M C and Hamadani, Christine M and d'Auvergne, Ava and Guo, Junling and Tanner, Eden E L and Shields, C Wyatt},
  title = {Ionic Liquid‐Mediated Delivery of Ruxolitinib to Skin Using an Adhesive Topical Hydrogel System},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {27},
  doi = {10.1002/adhm.202501838}
}
Kostenlos starten →